Lactic acid induces transcriptional repression of macrophage inflammatory response via histone acetylation.

CP: Immunology CP: Metabolism epigenetic reprogramming histone acetylation immunosuppression inflammation inflammatory bowel disease lactic acid macrophage metabolism metabolite sensing tissue microenvironment

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
07 Feb 2024
Historique:
received: 09 08 2023
revised: 09 12 2023
accepted: 22 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: aheadofprint

Résumé

Lactic acid has emerged as an important modulator of immune cell function. It can be produced by both gut microbiota and the host metabolism at homeostasis and during disease states. The production of lactic acid in the gut microenvironment is vital for tissue homeostasis. In the present study, we examined how lactic acid integrates cellular metabolism to shape the epigenome of macrophages during pro-inflammatory response. We found that lactic acid serves as a primary fuel source to promote histone H3K27 acetylation, which allows the expression of immunosuppressive gene program including Nr4a1. Consequently, macrophage pro-inflammatory function was transcriptionally repressed. Furthermore, the histone acetylation induced by lactic acid promotes a form of long-term immunosuppression ("trained immunosuppression"). Pre-exposure to lactic acid induces lipopolysaccharide tolerance. These findings thus indicate that lactic acid sensing and its effect on chromatin remodeling in macrophages represent a key homeostatic mechanism that can provide a tolerogenic tissue microenvironment.

Identifiants

pubmed: 38329873
pii: S2211-1247(24)00074-3
doi: 10.1016/j.celrep.2024.113746
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113746

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Weiwei Shi (W)

Department of Immunology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.

Tiffany J Cassmann (TJ)

Department of Immunology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.

Aditya Vijay Bhagwate (AV)

Departments of Health Science Research, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.

Taro Hitosugi (T)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.

W K Eddie Ip (WKE)

Department of Immunology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA; Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA. Electronic address: ip.eddie@mayo.edu.

Classifications MeSH